CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Ann: Positive Final Results in Stroke Study CUV801, page-17

  1. 761 Posts.
    lightbulb Created with Sketch. 205
    My view is that it isn't about reducing the SOI or even increasing the price short term. They could do a sharesplit and then the buy back, if SOI is a concern. What it does achieve is increase the percentage of the company each shareholder owns so that any future success is shared across less holders.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.